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Electronic structure of 3-(2-arylamino-4-aminothiazol-5-oyl)pyridine derivatives are investigated theoretically using 
B3LYB/6-31G (d,p) method. The energy gap between HOMO-LUMO and several thermodynamic properties in the ground 
state are calculated by means of B3LYP hybrid density functional theory (DFT) method together with 6-31G basis sets. 
A series of pyridinyl thiazoles were synthesized and characterized. The molecular docking studies were done using PyRx 
virtual screening tool in the active site of Hepg-2 (PDB code 4mmh) to study the hydrogen bonding interaction of these 
analogs. ADME properties and the hydrophobicity are found to be critical for activity. It is observed that all the synthesized 
compounds can be used orally as good drug candidates and the docking scores are comparable to the standard compounds. 
The compound C3 is found to have the highest activity against the cancer (PDB code: 4mmh)  protein. 
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In the recent days heterocyclic compounds like pyridine 
has been used very frequently as a proton acceptor in 
hydrogen bonded complexes1-2. All the pyridine 
derivatives are used as non-linear materials3 and photo 
chemicals4–9. Some of the pyridine derivatives form an 
acceptor fragment of 2-adamantylamino-5-nitropyridine 
(AANP). Final crystal shows the large optical non-
linearity10. Pyridine derivatives are involved in many 
biological activities with applications in pharmaceutical 
drugs and agricultural products 11–13. Complexes with 
metals are biologically important ligands are sometimes 
more effective than free ligands. Many pyridine 
derivatives are used to the treatment of certain brain 
diseases, and prodrugs for treating neuronal damage 
caused by stroke. Pyridine derivatives are prepared from 
thiourea derivatives have been shown to have 
cholesterol lowering properties, anti cancer and anti-
inflammatory agents11. And its derivatives continue to 
attract the attention of biologists because of their wide 
use in the treatment of the biological systems. Many 
articles have been published on the use of these 
compounds as antimicrobial12–14, antifungal15, anti-
inflammatory activity16-17, anesthetic18 and antiviral 
drugs19-20. Hence the structural and medicinal properties 
of thiazole analogs, we obtained a detailed investigation 
on the electronic properties, molecular structure, 
biological activity and vibrational spectra of the 
pyridinylthiazole derivatives. The literature inspired us 
to study this theoretical and experimental vibrational 
research 21-22. A well ordered quantum chemical and 
spectroscopic study of the feasible conformations and 
their relative stabilities has been performed in this paper. 
Bond length, bond angle ,electronic properties, wave 
number, intensity of the vibrational bands and optimized 
geometry of feasible conformers were obtained by 
density functional theory (DFT) utilize B3LYP using 
6-31G(d,p) basis set. The infrared spectrum calculated is 
compared with the results of observed Fourier transform 
FT-IR spectrum and the comprehensive assignments of 
the vibrational spectra have been compared with the 
vibrational frequencies predicted theoretically. DFT 
methods, mainly hybrid functional methods have be a 
significant chemical quantum tool for the assessment of 
the electronic structure of molecules. B3LYP functional 
and standard valence basis set 6-31G (d,p) has been 
shown to provide a perfect agreement between accuracy 
and computational assignment of vibrational spectra for 
huge and medium-sized molecules 23. 
Experimental Section 
General procedure 
Resultant compounds was prepared through the 
reaction of aryl-2-(N,N-dimethylamidino)thiourea in 
DMF and 3-bromoacetylpyridine. The resulted 




mixture was stirred well and triethylamine was added. 
Then the reaction mixture was heated to about 80-85ºC. 
Then it was allowed to cool in ice-cold water. An orange 
coloured precipitate was obtained and filtered. Washed 
with distilled water and finally dried. The obtained crude 
product was crystallized from ethanol: water (2:1) 
mixture produce slightly orange coloured crystalline 
solid. The proton NMR data are tabulated. 
 
3-(2-Phenylamino-4-aminothiazol-5-oyl)pyridine (C1) 
7.01(t, 1H, 1ArH), 7.21-7.34(m, 3H, H-5, 2ArH), 
7.50(t, 1H, H-6), 8.17(d,1H, H-4),6.46(d, 2H, 2ArH), 
8.17(d, 1H), 8.79(br, 1H, NH), 10.97 (s, 1H, NH). 
 
3-(2-Chloroamino-4-aminothiazol-5-oyl)pyridine (C2) 
7.51(t, 1H, H-5), 8.78(d, 2H, 2ArH), 7.49(t, 1H, H-
6), 7.44(s, 1H, H-3), 8.13(d,1H, H-4), 6.44(d, 2H, 





2.35(s, 3H, CH3), 6.81(d, 2H, 2ArH), 7.45(t,1H, H-
5),7.39-7.43(m, 2H, H-3, H-6), 6.34(d,2H, 2ArH), 
7.60(d, 1H, H-4), 7.79(d, 1H, H-7),8.74(br, 1H, NH), 




3.73(s, 3H, OCH3), 6.52(d, 2H, 2ArH), 7.48(t, 1H,  
H-5), 7.17-7.79.(m, 2H, H-3, H-6), 7.54(d, 2H, 2ArH), 
8.14(d, 1H, H-4), 7.74(d,1H, H-7),8.79(br, 1H, NH), 




1.33(t, 3H, CH3), 3.98(s, 2H, CH2), 6.53(d,2H, 
2ArH), 7.51 (t,1H, H-5), 7.59-7.62(m, 2H, H-3, H-6), 
7.48 (d, 2H, 2ArH), 7.83(d,1H, H-4), 7.79(d,1H, H-7), 
8.78(br, 1H, NH), 11.08 (s, 1H, NH). 
 
Computational details 
Gaussian 09 package is used to calculate the 
geometry optimization and harmonic frequencies of 
pyridinylthiazole molecules was performed with the 
B3LYP, that is, Becke three hybrid exchange, were 
utilized in the DFT calculation with 6-31G basis sets. 
 
Docking study 
Docking studies were extinct using AutoDock Vina 
in PyRx virtual shielding tool, only for the 
compounds which obey Lipinski rule of five.  
On the basis of lowest binding affinity value 
AutodockVina dispensed in ranked nine best  
docking modes. For the study of computer-aided  
drug design, the most powerful visualization engine  
is PyRx. 
 
Protein structure preparation 
The X-ray crystallographic structure of cancer 
(PDB code: 4mmh) protein was found from 
Brookhaven protein data bank. The observed protein 
was found to have ligand, Water molecules and 
ligands were removed from the complex. Atomic 
charges were computed by OPLS AA force field and 
the protein structure was optimized then saved as 
PDB file used for docking studies. 
 
Preparation of ligands 
With the help of ACD\ChemSketch 1.1 software all 
the compounds were converted into 2D structure to 
3D. Followed by all the structures were optimized 
with Avagadro package. Derived compounds were 
examined for their hydrophobicity because of protein 
molecules are hydrophobic property and most of the 
binding sites is hydrophobic. The slowly absorbed 
drugs are hydrophilic drugs. Determined binding sites 
and reported docking score of the ligand into 4mmh 
has successfully analyzed by PyRx. 
 
Results and Discussion 
 
Molecular geometry 
In the geometrical calculations the most stable 
optimized geometry obtained from B3LYP/6-31G 
(d,p) method and the scheme of numbering the atoms 
of the all compounds(C1,C2,C3,C4 and C5) are 
shown in Figure 1. Molecular property, dipole 
moment and its spectroscopic transitions are 
calculated using molecular symmetry. 
 
Structural properties 
Bond length and bond angle of the optimized 
structural compounds are determined at B3LYP 
method using 6-31G (d,p) basis sets are presented in 
Table I and Table II. All the structural parameters 
derived from B3LYP/6-31G (d,p) method were only 
considered for comparative discussion of the 
compounds due to the more responsible of this 
method. Observed mean C-C bond distance calculated 
1.40 and C-H 1.08 bond lengths are found to be not 
significantly deviated with the substitutions at  







Figure 1 — Optimized structure of synthesized compounds (C1, C2, C3, C4, C5) 
 
Table I — Bond length data of derived compounds 
Atom Bond Length 
C1 C2 C3 C4 C5 
S1-C2 1.83931 1.83632 1.83998 1.82029 1.84019 
C2-N3 1.31283 1.31203 1.31339 1.28684 1.31440 
N3-C4 1.38574 1.38713 1.38526 1.38007 1.34696 
C4-C5 1.40955 1.40874 1.40986 1.38102 1.41000 
C5-C6 1.42542 1.42663 1.42502 1.41893 1.42462 
C6-O15 1.28339 1.28254 1.28368 1.24185 1.28398 
C6-C7 1.49439 1.49380 1.49510 1.49302 1.49464 
C7-C8 1.40480 1.40484 1.40480 1.38444 1.40486 
C8-H16 1.08356 1.08356 1.08355 1.06816 1.08351 
C8-N9 1.35138 1.35119 1.35144 1.33102 1.35144 
N9-C10 1.35076 1.35079 1.35075 1.32852 1.35069 
     (contd.)




Table I — Bond length data of derived compounds    (contd.) 
Atom Bond Length 
C1 C2 C3 C4 C5 
C10-H17 1.08500 1.08494 1.08502 1.07034 1.08500 
C10-H11 1.39974 1.39979 1.39972 1.38343 1.39970 
C11-H18 1.08440 1.08435 1.08442 1.07003 1.08441 
C11-C12 1.39408 1.39405 1.39409 1.37853 1.39410 
C12-H19 1.08364 1.08364 1.08364 1.06958 1.08361 
C4-N14 1.34673 1.34653 1.34682 1.32604 1.34696 
N14-H22 1.01741 1.01733 1.01746 1.00135 1.01756 
N14-H21 1.00651 1.00652 1.00649 1.99565 1.00640 
C2-N13 1.35782 1.36029 1.35675 1.33419 1.35529 
N13-H20 1.01055 1.01041 1.01052 0.99942 1.01039 
N13-C23 1.42030 1.41704 1.42104 1.41888 1.42241 
C23-C24 1.40776 1.40787 1.40668 1.39334 1.40947 
C24-C25 1.39456 1.39455 1.39334 1.37214 1.38866 
C24-H29 1.08735 1.08661 1.08747 1.07295 1.08704 
C25-H30 1.08510 1.08278 1.08617 1.06929 1.08329 
C25-C26 1.40043 1.39349 1.40590 1.38857 1.40416 
C26-C27 1.98756 1.39170 1.40373 1.37835 1.39985 
C27-C28 1.3988 1.39862 1.39792 1.38746 1.40057 
C27-H31 1.08535 1.08302 1.08634 1.06944 1.08278 
C28-H32 1.07998 1.07995 1.08009 1.06488 1.08015 
C26-H33 1.08467 - - - - 
C26-Cl33 - 1.82575 - - - 
C26-C33 - - 1.51235 - - 
C33-H34 - - 1.09502 - - 
C33-H36 - - 1.09879 - - 
C33-H35 - - 1.09562 - - 
C26-O33 - - - 1.37110 1.38980 
O33-C34 - - - 1.43628 1.46171 
C34-H37 - - - 1.07748 - 
 














C1 C2 C3 C4 C5 
 
S1 –C2-N3 115.12 115.24 115.10 114.75 115.09 
C2-N3-C4 112.4 112.3 112.42 113.42 112.4 
N3-C4-C5 117.4 117.2 117.4 117.4 117.4 
C4-C5-C6 123.78 123.79 123.78 123.78 123.76 
C5-C6-C7 123.37 123.37 123.37 121.91 123.39 
C7-C8-H16 121.40 121.47 121.40 121.40 121.41 
C7-C8-N9 123.33 123.32 123.32 121.37 123.34 
C8-N9-C10 118.08 118.08 118.08 119.03 118.08 
C10-C11-H18 120.29 120.29 120.29 120.48 120.29 
C10-C11-C12 118.71 118.71 118.71 118.38 118.71 
C11-C12-H19 121.88 121.86 121.88 121.60 121.89 
C12-C7-C6 117.7 117.80 117.76 116.86 117.76 
     (contd.)


















 C1 C2 C3 C4 C5 
 
C2-N13-H20 115.7 115.7 115.8 116.62 115.88 
N3-C4-N14 118.74 118.75 118.75 117.65 118.78 
C4-N14-H21 119.67 119.75 119.65 119.22 119.66 
C4-N14-H22 116.60 116.61 116.58 118.02 116.54 
N13-C23-C24 116.64 116.87 116.85 117.19 116.86 
C23-C24-H29 119.847 120.08 119.91 119.93 119.96 
C24-C25-C26 120.23 118.90 121.16 120.42 120.03 
C24-C25-H30 119.46 120.48 119.20 121.19 - 
C25-C26-C27 119.29 121.41 117.62 118.88 119.60 
C25-C26-H33 120.28 - 121.05 - - 
C26-C27-H31 119.91 120.27 119.23 120.82 120.97 
C26-C27-C28 121.21 119.80 122.14 120.899 120.45 
C27-C28-C32 121.29 120.79 121.11 120.55 120.60 
C27-C28-C23 119.17 119.61 119.29 120.17 119.93 
C25-C26-Cl33 - 119.15 - - - 
C26-C33-C35 - - 111.49 - - 
C25-C26-O33 - - - 116.19 115.90 
C26-O33-C34 - - - 120.63 119.23 
O33-C34-H36 - - - 111.31 109.40 
O33-C34-C37 - - - - 106.74 
C34-C37-H40 - - - - 110.4 
 
 
different positions. Bond angles are also in excellent 
agreement in all levels of calculations. The computed 




Electronic properties of HOMO, LUMO were 
calculated. The HOMO–LUMO energy gap,  
electron affinity, electronegativty, hardness of 
pyridinylthiazoles have been calculated at the B3LYP/6-
31G level are given in the following table (Table III, 
Figure 2). 
Docking energy evaluation of synthesized compounds 
According to the docking studies to predict the best 
conformational position within the active region of all 
the synthesized ligands, were docked against receptor 
molecule. Docked complexes were analysed on the 
basis of minimum energy values (kcal/mol) and 
bonding interaction pattern such as hydrogen and 
hydrophobic bonds, respectively. However, all these 
compounds have no big docking energy value 
difference more than standard error value (Table IV, 
Table V, Figure 3). The standard error for Autodock is 
reported as 2.5 kcal/mol (http://autodock.scripps.edu/). 
 




C1 C2 C3 C4 C5 
HOMO -0.2518 -0.26188 -0.24648 -0.32381 -0.25498 
LUMO -0.04295 -0.04963 -0.04140 0.09667 -0.04096 
HOMO-LUMO 0.20886 0.21225 0.20508 0.42048 0.21402 
I 0.2518 0.26188 0.24648 0.32381 0.25498 
A 0.04295 0.04963 0.04140 0.09667 0.04096 
Χ 0.1339 0.15575 0.14394 0.21024 0.14797 
Ղ 0.10443 0.10612 0.10254 0.11357 0.10701 
I-Ionisation potential; A-Electron affinity; χ-Electronegativity; ղ-Hardness 







Figure 2 — HOMO and LUMO structures of C1, C2, C3, C4 and C5 













C1 Phenyl -7.2 GLU-245,ALA-246,GLN-247,PHE-251 
C2 Chloro -7.3 ALA-246,SER-255 
C3 Methyl -7.5 SER-255 
C 4 Methoxy -7.3 SER-255,GLN-247,ALA-246,PRO-189 
C5 Ethoxy -7.2 GLU-245,SER-255 
 
Table V — Abbreviation of 3-(2-arylamino-4-aminothiazol-5-oyl)pyridine 
Abbreviation Compd 








Figure 3 — Docking images of C1, C2, C3, C4 and C5 
 






In summary, electronic structures of all the derived 
compounds are investigated theoretically at B3LYP/6-
311G (d, p). Above studied compounds are found to 
be non-planar. Mullikan and natural charge 
distribution of the compounds C1–C5 were studied 
which indicated the electronic charge distribution. 
NBO analysis of the synthesized compounds C1–C5 
indicated the intermolecular charge transfer between 
the bonding and antibonding orbital's. HOMO-LUMO 
energy gap confirmed that, the charge transfer takes 
place within the molecule. And the molecular docking 
study of the derived compounds concerned the active 
site of enzyme cytochrome Hepg-2 using PyRx virtual 
screening tool. The compound C3 with the highest 
docking score showed four hydrogen bonding 
interactions with 4mmh. The data shows that these 
compounds can be used as good drug. It is concluded 
from the binding mode analysis that these novel 
compounds with electron withdrawing and electron 
donating substituents can be utilized for development 
of anticancer inhibitors and gives a strong platform 
for the new structure based drug design. 
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